Search Results - "Orhan, Ilkay E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease? by Orhan, Ilkay E, Deniz, Fatma S S

    Published in Current pharmaceutical design (2021)
    “…Xanthine oxidase (EC 1.17.3.2) (XO) is one of the main enzymatic sources that create reactive oxygen species (ROS) in the living system. It is a dehydrogenase…”
    Get more information
    Journal Article
  2. 2

    Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies by Oresanya, Ibukun O, Orhan, Ilkay E

    Published in Current drug targets (01-01-2024)
    “…L. (RO, rosemary) is a well-known medicinal, aromatic, and culinary herb with traditional use in European folk medicine against memory deficits and…”
    Get more information
    Journal Article
  3. 3

    Dual Monoamine Oxidase and Cholinesterase Inhibitors with Different Heterocyclic Scaffolds by Gulcan, Hayrettin O, Orhan, Ilkay E

    Published in Current topics in medicinal chemistry (01-01-2021)
    “…For the last two decades, there has been research interest on the design of molecules possessing dual inhibitory potential on cholinesterase and monoamine…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Naringenin and atherosclerosis: a review of literature by Orhan, Ilkay E, Nabavi, Seyed F, Daglia, Maria, Tenore, Gian C, Mansouri, Kowsar, Nabavi, Seyed M

    Published in Current pharmaceutical biotechnology (01-01-2015)
    “…Atherosclerosis is a multifactorial disease mainly caused by deposition of low-density lipoprotein (LD) cholesterol in macrophages of arterial walls…”
    Get more information
    Journal Article
  6. 6

    Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases by Gulcan, Hayrettin O, Orhan, Ilkay E, Sener, Bilge

    Published in Current pharmaceutical biotechnology (01-01-2015)
    “…Dual action of galanthamine as potent cholinesterase inhibitor and nicotinic modulator has attracted a great attention to be used in the treatment of AD…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Selective cholinesterase inhibitors from Buxus sempervirens L. and their molecular docking studies by Orhan, Ilkay E, Khan, Mahmud T H, Erdem, Sinem A, Kartal, Murat, Sener, Bilge

    Published in Current computer-aided drug design (01-12-2011)
    “…In this work, two alkaloids namely (+)-buxabenzamidienine (1) and (+)-buxamidine (2) were isolated from Buxus sempervirens, using bioassay-guided fractionation…”
    Get more information
    Journal Article
  9. 9

    Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering by Orhan, Ilkay E

    Published in Current pharmaceutical biotechnology (01-01-2014)
    “…Flavonoids are one of the most abundant secondary metabolites having a polyphenolic structure in plant and animal species with various desired pharmacological…”
    Get more information
    Journal Article
  10. 10

    Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb by Orhan, Ilkay Erdogan

    Published in Current medicinal chemistry (01-01-2018)
    “…Crataegus oxyacantha L. (syn. C. rhipidophylla Gand.) (Rosac-eae) is one of the two medicinally recognized hawthorn species in European Pharmacopeia…”
    Get more information
    Journal Article
  11. 11

    Blessings in disguise: a review of phytochemical composition and antimicrobial activity of plants belonging to the genus Eryngium by Erdem, Sinem Aslan, Nabavi, Seyed Fazel, Orhan, Ilkay Erdogan, Daglia, Maria, Izadi, Morteza, Nabavi, Seyed Mohammad

    Published in Daru (14-12-2015)
    “…Medicinal and edible plants play a crucial role in the prevention and/or mitigation of different human diseases from ancient times to today. In folk medicine,…”
    Get full text
    Journal Article
  12. 12

    Outstanding effect of the conformational restriction of isoquinolines: hints for the development of optimized antimicrobial agents by Ozcelik, Berrin, Sheikh, Javed, Orhan, Ilkay E., Juneja, Harjeet, Bennani, Brahim, Kerbal, Abdelali, Cavalcanti, S. M. T., Leite, Ana C. L., Ben Hadda, Taibi

    Published in Research on chemical intermediates (01-09-2013)
    “…Conformational restriction constitutes a useful strategy of molecular modification for the design of new potential drug candidates. Herein we present the…”
    Get full text
    Journal Article